Literature DB >> 20922388

Managing BRCA mutation carriers in China.

Kyriakos Kalogerakos.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 20922388     DOI： 10.1007/s00268-010-0788-6

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  14 in total

1.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

Review 2.  Systems medicine: a real approach for future personalized oncology?

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

3.  Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment.

Authors:  Dimitrios H Roukos; Christos Katsios; Theodore Liakakos
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

4.  Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

5.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

6.  From tumor size and HER2 status to systems oncology for very early breast cancer treatment.

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Expert Rev Anticancer Ther       Date:  2010-02       Impact factor: 4.512

Review 7.  Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks.

Authors:  Dimitrios H Roukos; Dimosthenis E Ziogas; Christos Katsios
Journal:  Expert Rev Anticancer Ther       Date:  2010-08       Impact factor: 4.512

Review 8.  Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-01       Impact factor: 5.225

Review 9.  Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Authors:  Dimosthenis Ziogas; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-03-26       Impact factor: 5.344

10.  Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

Authors:  Kelly A Metcalfe; Jan Lubinski; Parviz Ghadirian; Henry Lynch; Charmaine Kim-Sing; Eitan Friedman; William D Foulkes; Susan Domchek; Peter Ainsworth; Claudine Isaacs; Nadine Tung; Jacek Gronwald; Shelly Cummings; Teresa Wagner; Siranoush Manoukian; Pål Møller; Jeffrey Weitzel; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2008-01-14       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.